Finance

Lists
Q2 2026 earnings • released • EPS miss -3.91% • Revenue miss -2.30%
See results
SRT3:ETR
Sartorius AG Preference Shares
€221.00
-0.36%
(-0.80) 1D
Jul 24, 5:35:16 PM GMT+2  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for SRT3...
Open
€223.60
High
€224.90
Low
€214.30
Mkt. cap
14.88B
Avg. vol.
109.16K
Volume
115.87K
Dividend
0.33%
Quarterly dividend
€0.18
Ex-dividend date
Mar 27, 2026
P/E ratio
93.79
52-wk high
€267.70
52-wk low
€175.95
EPS
€2.36
Shares outstanding
37.44M
No. of employees
14K
Open
€223.60
High
€224.90
Low
€214.30
Mkt. cap
14.88B
Avg. vol.
109.16K
Volume
115.87K
Dividend
0.33%
Quarterly dividend
€0.18
Ex-dividend date
Mar 27, 2026
P/E ratio
93.79
52-wk high
€267.70
52-wk low
€175.95
EPS
€2.36
Shares outstanding
37.44M
No. of employees
14K
News stories
From sources across the web
Profile
Sartorius AG is an international supplier of pharmaceutical and laboratory equipment. Founded in 1870, the company is headquartered in Göttingen, Germany. It provides tools and services for the biopharmaceutical industry. The company operates through two divisions: Bioprocess Solutions and Lab Products & Services. Wikipedia
About Sartorius AG Preference Shares
CEOMichael Grosse
Employees14.3K
Founded1870
Headquarters-
SectorHealth care
Websitesartorius.com
Last report
Jul 23, 2026
Fiscal period
Q2 2026
EPS / Est. (EUR)
€1.29 / €1.34
-3.91%miss
Revenue / Est. (EUR)
911.80M / 933.26M
-2.30%miss
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in EUR
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in EUR
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
843.20M
927.60M
899.10M
911.80M
Cost of goods sold
450.00M
531.20M
484.60M
478.70M
Cost of revenue
450.00M
531.20M
484.60M
478.70M
Research and development expenses
40.40M
41.50M
49.10M
47.10M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
218.70M
223.10M
221.30M
221.30M
Operating expense
263.60M
227.70M
260.70M
269.00M
Total operating expenses
713.60M
758.90M
745.30M
747.70M
Operating income
129.60M
168.70M
153.80M
164.10M
Other non operating income
100.00K
-26.20M
100.00K
-100.00K
EBT including unusual items
85.00M
81.60M
111.00M
127.00M
EBT excluding unusual items
85.00M
109.70M
111.00M
127.00M
Income tax expense
22.90M
37.60M
30.00M
34.30M
Effective tax rate
26.94%
46.08%
27.03%
27.01%
Other operating expenses
4.50M
-36.90M
-9.70M
600.00K
Net income
43.80M
30.20M
56.20M
65.90M
Net profit margin
5.19%
3.26%
6.25%
7.23%
Earnings per share
1.08
1.26
1.20
1.29
Interest and investment income
4.80M
17.40M
20.10M
14.80M
Interest expense
-49.50M
-31.80M
-63.00M
-51.80M
Net interest expenses
-44.70M
-14.40M
-42.90M
-37.00M
Depreciation and amortization charges
-
-
-
-
EBITDA
233.20M
177.60M
260.40M
267.40M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

What's on your mind?
What's going on with the markets today?
Explore what’s possible
Create a portfolio
Create a task
Deep Search
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer